Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 41.3214.2638.52736.19-

What is the latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA is 41.32 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202441.32
Mar202314.26
Mar202238.52
Mar2021736.19
Mar2020-

How is Price to Cash Earnings (PCE) of ORCHID PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 41.32
189.76
Mar2023 14.26
-62.98
Mar2022 38.52
-94.77
Mar2021 736.19
0
Mar2020 0 -

Other Financial Ratios of ORCHID PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹7,828.8 Cr -3.7% -13.8% 124.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-3.7%

-13.8%

124.7%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses